Identification of a potent endogenous benzodiazepine binding inhibitor from bovine cerebral cortex
Medina, J.H.; Novas, M.L.; De Robertis, E.; Pena, C.; Paladini, A.C.
Advances in Biochemical Psychopharmacology 42: 47-56
1986
ISSN/ISBN: 0065-2229 PMID: 2876590 Document Number: 268530
Document emailed within 1 workday
Related Documents
Medina, J.H.; De Robertis, E.; Novas, M.L.; Peña, C.; Paladini, A.C. 1986: Endogenous benzodiazepine binding inhibitors from bovine cerebral cortex: isolation and purification Advances in Biochemical Psychopharmacology 41: 149-160Korneev, A.Ia.; Faktor, M.I. 1983: Detection of an endogenous inhibitor of benzodiazepine receptor binding Biulleten' Eksperimental'noi Biologii i Meditsiny 96(7): 64-65
Lowenstein, P.R.; González Solveyra, C.; Cardinali, D.P. 1984: Micromolar benzodiazepine binding sites of central type characteristics are present in the cerebral cortex of the rat Acta Physiologica et Pharmacologica Latinoamericana: Organo de la Asociacion Latinoamericana de Ciencias Fisiologicas y de la Asociacion Latinoamericana de Farmacologia 34(4): 441-443
Tamura, M.; Konishi, F.; Inagami, T. 1993: A novel endogenous sodium-pump inhibitor in pig urine: purification and comparison with the inhibitor purified from bovine adrenal glands Journal of Cardiovascular Pharmacology 22(Suppl 2): S47-S50
Trifiletti, R.R.; Snowman, A.M.; Whitehouse, P.J.; Marcus, K.A.; Snyder, S.H. 1987: Huntington's disease: increased number and altered regulation of benzodiazepine receptor complexes in frontal cerebral cortex Neurology 37(6): 916-922
French, J.F.; Matlib, M.A. 1988: Identification of a high-affinity peripheral-type benzodiazepine binding site in rat aortic smooth muscle membranes Journal of Pharmacology and Experimental Therapeutics 247(1): 23-28
Van Heek, M.; France, C.F.; Compton, D.S.; McLeod, R.L.; Yumibe, N.P.; Alton, K.B.; Sybertz, E.J.; Davis, H.R. 1997: In vivo metabolism-based discovery of a potent cholesterol absorption inhibitor, SCH58235, in the rat and rhesus monkey through the identification of the active metabolites of SCH48461 Journal of Pharmacology and Experimental Therapeutics 283(1): 157-163
Gabrielian, E.S.; Amroian, E.A.; Matevosian, R.S. 1983: Role of endogenous prostaglandins in the mechanism of action of CO2 and O2 on the morphofunctional state of the capillary system in the cat cerebral cortex Biulleten' Eksperimental'noi Biologii i Meditsiny 96(9): 67-70
Kannan, V.M.; Appukuttan, P.S. 1994: Major bovine brain stem glycoproteins sugar-specifically recognized by endogenous 14 kDa galactose-binding lectin Indian Journal of Biochemistry and Biophysics 31(3): 160-164
Aloyo, V.J. 1992: Identification and characterization of delta opioid binding sites in the bovine pineal Journal of Pharmacology and Experimental Therapeutics 262(1): 292-297
Perez, J.; Tinelli, D.; Bianchi, E.; Brunello, N.; Racagni, G. 1991: CAMP binding proteins in the rat cerebral cortex after administration of selective 5-HT and NE reuptake blockers with antidepressant activity Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 4(1): 57-64
Petkov, V.D.; Petkov, V.V.; Popova, J.; Konstantinova, E. 1987: Changes in the 5-HT-binding sites in the cerebral cortex, striatum and hypothalamus of rats during ageing and under the effect of dopaminergic agents Acta Physiologica et Pharmacologica Bulgarica 13(1): 11-19
Evans, R.A.; Watson, M.; Yamamura, H.I.; Roeske, W.R. 1985: Differential ontogeny of putative M1 and M2 muscarinic receptor binding sites in the murine cerebral cortex and heart Journal of Pharmacology and Experimental Therapeutics 235(3): 612-618
Rägo, L.; Saano, V.; Tupala, E.; Nieminen, S.A.; Airaksinen, M.M. 1992: 3H-atipamezole binding sites in mouse cerebral cortex: possible involvement of alpha 2-adrenoceptors in sexual behavior Methods and Findings in Experimental and Clinical Pharmacology 14(1): 23-27
Nasseri, A.; Minneman, K.P. 1987: Relationship between alpha 2-adrenergic receptor binding sites and the functional receptors inhibiting norepinephrine release in rat cerebral cortex Molecular Pharmacology 32(5): 655-662
Sun, D.X.; Rui, Y.C.; Zeng, G.Q.; Zhu, J.; Shen, Y.A. 1992: Specific binding sites of platelet activating factor on the intact bovine cerebral microvascular endothelial cells and antagonism of drugs Zhongguo Yao Li Xue Bao 13(4): 326-329
Knight, K.L.; Suter, M.; Becker, R.S. 1988: Genetic engineering of bovine Ig. Construction and characterization of hapten-binding bovine/murine chimeric IgE, IgA, IgG1, IgG2, and IgG3 molecules Journal of Immunology 140(10): 3654-3659
Murphy, N.R.; Leinbach, S.S.; Hellwig, R.J. 1995: A potent, cost-effective RNase inhibitor Biotechniques 18(6): 1068-1073
Mostafizar, M.; Haque, P.; Mazid, A.; Shohel, M.; Shazly, G.; Kazi, M.; Reza, H.M. 2017: Characterization of Binding Sites of Clopidogrel and Interference of Linoleic Acid at the Binding Site on Bovine Serum Albumin Acta Poloniae Pharmaceutica 74(1): 119-125
Brugge, W.R.; Rosenfeld, M.S. 1987: Impairment of starch absorption by a potent amylase inhibitor American Journal of Gastroenterology 82(8): 718-722